The FDA/CDER normally takes a long time to approve a drug: anywhere from 3 to 13 years. Although the process is often criticized as a prime reason for the high cost of pharmaceuticals in the United States, it serves as a preventative measure against unsafe drugs entering the market and allows for plenty of time to clear the bribery checks and play a few rounds of free golf*.
It should be cause for concern that the U.S. government somehow “fast tracked” the approval process for a swine flu…I mean H1N1…vaccine that is going to be made available for children as young as two years old. How do you fast track safety? How do you suddenly decide that testing is no longer necessary before shoving a needle into a child’s arm and injecting it with a virus? I would like to meet the person who believes that it takes about five years to test the safety of fish oil for seniors, but only 6 months to test a brand new virus never before seen on Earth and create a vaccine for the entire human population.
If that makes sense, you’re a smarter person than I am. Clearly, the pharmaceutical companies got their bribe money together quickly and called their friends in FDA to get things done.*
Before you decide to vaccinate yourself or your child against the swine flu (which is no more dangerous or painful than the regular flu) remember that the safety process was compromised and paid for with bribe money*. You could accomplish the same goal by kissing someone with the swine flu because they probably went through the same amount of preventative screening as the “vaccine”.
*The FDA has long served as an employment pool for pharmaceutical companies. Big pharma has hired former FDA employees directly for more than 20 years. Also, due to the Prescription Drug User Fee Act in 1992, funding for the FDA’s drug approval process is now dependent on payments from the pharmaceutical companies for as much as forty percent. In other words, if the drug companies didn’t pay the FDA to approve its drugs, the FDA approval process would end. See: http://usa.mediamonitors.net/content/view/full/27667